Clinical Trial Update: TC-6987 for the Treatment of Mild to Moderate Asthma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating TC-6987 for mild to moderate asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• TC-6987

Snippet

Sponsor: Targacept Inc. | Conditions: Asthma | Phase 2 | Status: COMPLETED